Özgür Akın Oto

690 citations
46 papers · 206 indexed · h-index 8
Topics
Renal Diseases and Glomerulopathies (17 papers)Renal Transplantation Outcomes and Treatments (9 papers)COVID-19 Clinical Research Studies (6 papers)

In The Last Decade

Özgür Akın Oto

37 papers receiving 203 citations

Peers

Özgür Akın Oto
Comparison fields: 5 of 56
  • Infectious Diseases 70
  • Nephrology 58
  • Molecular Biology 40
  • Immunology 38
  • Neurology 38
Replace Susan Hartzell with:
Susan Hartzell United States
Ahmet Burak Dirim Türkiye
Angelo Rigotti Italy
Maxime Espi France
Hamza Sakhi France
Evelyn Seelow Germany
Marion Crémoni France
F. J. Bemelman Netherlands
Jipin Jiang China
Gabriele Guglielmetti Italy
Özgür Akın Oto relative to Susan Hartzell United States Susan Hartzell's profile →
Citations per field
00.5×1.5×2.2×
Susan Hartzell · 1×
Citations per year

Countries citing papers authored by Özgür Akın Oto

Since Specialization
Citations

This map shows the geographic impact of Özgür Akın Oto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özgür Akın Oto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özgür Akın Oto more than expected).

Fields of papers citing papers by Özgür Akın Oto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özgür Akın Oto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özgür Akın Oto. The network helps show where Özgür Akın Oto may publish in the future.

Co-authorship network of co-authors of Özgür Akın Oto

This figure shows the co-authorship network connecting the top 25 collaborators of Özgür Akın Oto. A scholar is included among the top collaborators of Özgür Akın Oto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özgür Akın Oto. Özgür Akın Oto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 4
5 2
6 0
7 1
8 0
9 0
10 0
11 0
12 5
13 5
14 1
15 0
16 13
17 38
18 10
19 6
20 5

About Özgür Akın Oto

Özgür Akın Oto is a scholar working on Nephrology, Transplantation and Hematology, having authored 46 papers that have together received 206 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (17 papers), Renal Transplantation Outcomes and Treatments (9 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Nephrology (58 citations), Transplantation (16 citations) and Infectious Diseases (70 citations). Özgür Akın Oto has collaborated with scholars based in Türkiye, United States and India. Frequent co-authors include Halil Yazıcı, Ahmet Burak Dirim, Erol Demir, Aydın Türkmen, Seda Şafak, Semra Paydaş, Gülşah Şeydaoğlu, Sinan Yavuz, Umut Dişel and Yaşar Çalışkan. Their work appears in journals such as SHILAP Revista de lepidopterología, Environmental Science and Pollution Research and American Journal of Physiology-Renal Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026